Fang commented on a limitation of the clinical trial pointed out at the European Society for Medical Oncology (ESMO) 2022 Congress.
Guoqiang Ai, MD
Advertisement
Articles by Guoqiang Ai, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on CGTlive®
1
FDA Approves Waskyra as First Gene Therapy for Wiskott-Aldrich Syndrome
2
MDA 2026 to Bring Keynote Insights and Evolving Neuromuscular Care
3
CGTLive®’s Weekly Rewind – December 12, 2025
4
Around the Helix: Cell and Gene Therapy Company Updates – December 10, 2025
5
